Search
for
Sort by
Research 31–60 of 1000+
- 2′‐Fucosyllactose Alleviates Hair Loss in Testosterone‐Induced Androgenic Alopecia Mice
- Corrigendum: Stimulation of hair regrowth in an animal model of androgenic alopecia using 2-deoxy-D-ribose
- The Synthesis of 2,2-BIS(1-INDOL-3-YL)Acenaphthylene-1(2)-Ones Using Nanocatalysis: Fluorescent Sensing for Cu<sup>2+</sup> Ions
- DEVELOPING AND VALIDATING AN HPLC METHOD TO QUANTIFY SIMULTANEOUSLY DUTASTERIDE AND THEIR RELATED MOLECULES (DUTASTERIDE ACID, 2,5 BIS- (TRI FLUORO METHYL)-ANILINE AND DUTASTERIDE 17 α-EPIMER) IN CAPSULES
- 573 Hair follicles employ a 2-dimensional healing strategy to repair 3-dimensional injuries
- Efficacy and tolerance of 2,3-diphenylcyclopropenone in propylene glycol versus 2,3-diphenylcyclopropenone in isopropanol – a novel formula designed for the treatment of alopecia areata
- 2-Deoxy-2-[18F]fluoro-D-Glucose Positronen-Emissions-Tomographie/Computertomographie
- 2 Hair transplantation
- Chronic Toxicity Studies of the Potential Cancer Preventive 2-(Difluoromethyl)-<i>dl</i>-ornithine
- Topical Rice Bran Oil (Oryza sativa L.) Has The Same Effect With 2% Topical Minoxidil To Prevent Senile Alopecia Through Improved Vascular Endothelial Growth Factor (VEGF) Protein Expression, Hair Follicle Diameter And Length In Wistar Rats (Rattus norvegicus) Exposed To Ultraviolet B Light
- Application of 2-Chloro-7-Nitrobenzo-2-Oxa-1, 3-Diazol (NBDCL) for Spectrophotometric Determination of Finasteride in Pharmaceutical Formulation
- Faculty Opinions recommendation of A randomized, single-blind trial of 5% minoxidil foam once daily versus 2% minoxidil solution twice daily in the treatment of androgenetic alopecia in women.
- A quantitative hair growth assessment in androgenetic alopecia after application of two cosmetic lotions versus 2% topical minoxidil
- Abnormal differentiation of epidermis in transgenic mice constitutively expressing cyclooxygenase-2 in skin
- Reversal of Alopecia Areata Following Treatment With the JAK1/2 Inhibitor Baricitinib
- Keratin 17 mutations cause either steatocystoma multiplex or pachyonychia congenita type 2
- Overexpression of protein kinase C-α in the epidermis of transgenic mice results in striking alterations in phorbol ester-induced inflammation and COX-2, MIP-2 and TNF-α expression but not tumor promotion
- Chapter 2 The Human Keratin Genes and Their Differential Expression
- Dermatologic Changes Associated With Interleukin 2 Administration
- VEGF induces proliferation of human hair follicle dermal papilla cells through VEGFR-2-mediated activation of ERK
- Cyclooxygenase-2 overexpression in the skin of transgenic mice results in suppression of tumor development.
- Immunohistochemical localization of types 1 and 2 5α-reductase in human scalp
- Bone morphogenetic protein-2 (BMP-2) transactivates Dlx3 through Smad1 and Smad4: alternative mode for Dlx3 induction in mouse keratinocytes
- Effects of finasteride, a type 2 5-alpha reductase inhibitor, on fetal development in the rhesus monkey (Macaca mulatta)
- Alopecia areata is characterized by dysregulation in systemic type 17 and type 2 cytokines, which may contribute to disease‐associated psychological morbidity
- Tcf3 promotes cell migration and wound repair through regulation of lipocalin 2
- Association of biochemical hyperandrogenism with type 2 diabetes and obesity in Chinese women with polycystic ovary syndrome
- Topical 2% tofacitinib for children with alopecia areata, alopecia totalis, and alopecia universalis
- A family of type I keratin genes and the homeobox-2 gene complex are closely linked to the rex locus on mouse chromosome 11
- Tofacitinib 2% ointment, a topical Janus kinase inhibitor, for the treatment of alopecia areata: A pilot study of 10 patients